Bender Robert & Associates’s Kite Pharma, Inc. KITE Stock Holding History

Bender Robert & Associates’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,036	Closed	-$366K	–	51
2017 Q3	$366K	Buy	+2,036	New	+$284K	0.21%	39

Bender Robert & Associates's KITE Position: Q4 2017 in Review

Bender Robert & Associates sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 2,036 shares — an estimated $366K sold.

Bender Robert & Associates first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $366K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Bender Robert & Associates reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Bender Robert & Associates sold 2,036 Kite Pharma, Inc. shares in Q4 2017, an estimated $366K.
Bender Robert & Associates first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Bender Robert & Associates's Kite Pharma, Inc. position peaked at $366K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Bender Robert & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.